Spravato® for Treatment-Resistant Depression
Structured. Supervised. Clinically Intentional.
When depression doesn’t respond to standard treatment, the answer isn’t more of the same.
Spravato® offers a clinically different option—delivered with precision, medical oversight,
and clear goals.
At Mercurius Psychiatry, Spravato® is not treated as a last resort.
It’s treated as a focused, evidence-based pathway for patients who need a different mechanism of care.
What Is Spravato®?
Spravato® (esketamine) is an FDA-approved treatment for treatment-resistant depression and certain cases of major depressive disorder.
Unlike traditional antidepressants that work gradually through serotonin pathways, Spravato® acts on NMDA receptors, influencing glutamate activity in the brain—an area strongly linked to mood regulation, neuroplasticity, and emotional processing.
This difference matters when other treatments haven’t worked.
FDA-Certified Spravato® Provider
Mercurius Psychiatry is an FDA-certified Spravato® provider, which means:
Treatment is delivered on-site
Dosing follows strict clinical protocols
Each session includes medical supervision
Ongoing psychiatric follow-up is built into care
Spravato® is not prescribed casually.
It is administered with intention, structure, and accountability.
Who Spravato® May Be For
Spravato® may be appropriate if you:
Have tried multiple antidepressants without adequate relief
Experience persistent depression despite consistent treatment
Need an option beyond medication adjustments alone
Require a more biologically targeted intervention
Eligibility is determined through clinical screening, not assumptions.
How Spravato® Treatment Works
Spravato® treatment at Mercurius Psychiatry includes:
Comprehensive Evaluation: A full psychiatric assessment to determine clinical appropriateness.
Required Monitoring Period: Patients are observed after each session to ensure safety and stability.
On-Site Administration: Spravato® is self-administered under medical supervision in a controlled setting.
Ongoing Psychiatric Oversight: Treatment progress is monitored, adjusted, and reviewed—not left on autopilot.
Details matter.
Structure protects outcomes.
Why Delivery Matters:
Spravato® isn’t just about the medication—it’s about how it’s delivered.
At Mercurius Psychiatry:
Oversight is continuous
Screening is thorough
Follow-up is intentional
Education Is Part of Care
We believe patients deserve to understand:
What Spravato® does
Why it works differently
What realistic outcomes look like
Education isn’t extra—it’s essential.
Informed patients make stronger, more sustainable progress.
A Different Approach—Before It’s Too Late
Spravato® is often discovered after years of trial and error.
It doesn’t have to be.
If standard treatments haven’t brought relief, exploring a different clinical pathway sooner—not later—can change the trajectory.
Proudly Serving Fellow Veterans
Proudly Serving Fellow Veterans
© Copyright https://www.mercpsych.com/